Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five‐year follow‐up
Author:
Affiliation:
1. Department of Surgery Duke University Medical Center Durham North Carolina USA
2. Emory Transplant Center Emory University School of Medicine Atlanta Georgia USA
Funder
Bristol-Myers Squibb
U.S. Food and Drug Administration
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16121
Reference34 articles.
1. Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties
2. Costimulation Blockade with Belatacept in Renal Transplantation
3. A New Look at Blockade of T-cell Costimulation: A Therapeutic Strategy for Long-term Maintenance Immunosuppression
4. A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
5. Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Conversion From Mycophenolic Acid to Mammalian Target of Rapamycin Inhibitor Reduces the Incidence of Cytomegalovirus Replication in Belatacept-Treated Kidney-Transplant Recipients;Kidney International Reports;2024-06
2. New immunosuppressive protocols in living donor organ transplantation;Living Donor Organ Transplantation;2024
3. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024
4. Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future;Kidney International Reports;2023-12
5. Open letter to Bristol Myers Squibb: Belatacept; we aren’t done yet;American Journal of Transplantation;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3